Alexion ALXN1720-MG-301
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
May 10, 2023
End Date
July 28, 2026
Administered By
Neurology, Neuromuscular Disease
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
May 10, 2023
End Date
July 28, 2026